RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q4 2020 Results - Earnings Call Transcript
Relmada Therapeutics, Inc. (RLMD) Q4 2020 Earnings Conference Call March 23, 2021 16:30 ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - Chief Executive Officer Maged Shenouda - Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies Marc Goodman - Leerink Joon Lee - Truist Securities Jay Olson - Oppenheimer Presentation Operator Greetings. Welcome to the Relmada Therapeutics Incorporated Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I will now turn the call over to your host Tim McCarthy. Please go ahead. Tim McCarthy Thank you, operator. And thank you all for joining us this afternoon. With me on today’s call our Chief Executive Officer, Dr. Sergio Traversa; Chief Financial Officer, Maged Shenouda; and Chief Accounting and Compliance
For further details see:
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q4 2020 Results - Earnings Call Transcript